收费全文 | 15402篇 |
免费 | 909篇 |
国内免费 | 126篇 |
耳鼻咽喉 | 231篇 |
儿科学 | 287篇 |
妇产科学 | 274篇 |
基础医学 | 2003篇 |
口腔科学 | 785篇 |
临床医学 | 1283篇 |
内科学 | 3976篇 |
皮肤病学 | 334篇 |
神经病学 | 1612篇 |
特种医学 | 430篇 |
外科学 | 1783篇 |
综合类 | 39篇 |
预防医学 | 976篇 |
眼科学 | 234篇 |
药学 | 991篇 |
中国医学 | 105篇 |
肿瘤学 | 1094篇 |
2024年 | 17篇 |
2023年 | 145篇 |
2022年 | 314篇 |
2021年 | 525篇 |
2020年 | 329篇 |
2019年 | 412篇 |
2018年 | 551篇 |
2017年 | 355篇 |
2016年 | 467篇 |
2015年 | 550篇 |
2014年 | 717篇 |
2013年 | 960篇 |
2012年 | 1319篇 |
2011年 | 1229篇 |
2010年 | 685篇 |
2009年 | 642篇 |
2008年 | 977篇 |
2007年 | 1036篇 |
2006年 | 891篇 |
2005年 | 874篇 |
2004年 | 772篇 |
2003年 | 630篇 |
2002年 | 576篇 |
2001年 | 134篇 |
2000年 | 111篇 |
1999年 | 94篇 |
1998年 | 104篇 |
1997年 | 93篇 |
1996年 | 61篇 |
1995年 | 75篇 |
1994年 | 57篇 |
1993年 | 41篇 |
1992年 | 62篇 |
1991年 | 60篇 |
1990年 | 50篇 |
1989年 | 44篇 |
1988年 | 43篇 |
1987年 | 36篇 |
1986年 | 34篇 |
1985年 | 41篇 |
1984年 | 31篇 |
1983年 | 26篇 |
1982年 | 21篇 |
1981年 | 27篇 |
1980年 | 37篇 |
1979年 | 21篇 |
1977年 | 15篇 |
1976年 | 12篇 |
1975年 | 12篇 |
1967年 | 12篇 |
![点击此处可从《Neuromodulation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Background Drug-related problems are mostly preventable or predictable circumstances that may impact on health outcomes. Clinical pharmacy activities such as medication therapy management can identify and solve these problems, with potential to improve medication safety and effectiveness. Objective To evaluate ability of medication therapy management service to detect drug-related problems and prevent adverse drug events. This study also aimed to assess the risk factors for drugrelated problem occurrence. Setting Medical intensive care unit of a public tertiary hospital in Brazil. Methods Patients were evaluated by a clinical pharmacist, who provided medication therapy management service. Detected drug-related problems were categorized according to the Pharmaceutical Care Network Europe methodology and analyzed in multinomial regression to identify risk factors. Main outcome measure Potential risk factors for drug-related problem occurrence. Results The proposed medication therapy management service allowed detection of 170 drug-related problems that had potential to reach patients causing harm and other 50 unavoidable adverse events. Drug-related problems identified were more often associated with antibacterial use, caused by improper combinations or inadequate drug dosage. These problems required interventions that were accepted by the multidisciplinary team, resulting in more than 85% adherence and total problem solving. Main risk factors identified were previous diagnosis of kidney injury (OR?=?8.38), use of midazolam (OR?=?7.96), furosemide (OR?=?5.87) and vancomycin (OR?=?4.82). Conclusion Medication therapy management proved to be an effective method not only for drug-related problem detection, but also for adverse drug event prevention, contributing to improve patient safety.
相似文献Methods: Seven patients diagnosed with MAE and four patients diagnosed with LGS were selected from patients referred to our Child Neurology Unit. The patients were assessed both clinically (awake, sleep, Holter EEG, seizures frequency, and semiology) and neuropsychologically (IQ, language, attention, visuospatial and visuomotor abilities, and behavior). One representative case of each syndrome is presented here.
Results: The clinical picture of the MAE patient resembled that of an MAE condition associated with transitory epileptic encephalopathy. The neuropsychological findings suggest that electroclinical anomalies can temporarily affect cognitive and behavioral functioning. Early effective antiepileptic drug (AED) treatment was found to improve cognitive outcome. In contrast, LGS was associated with mental retardation, which persisted after seizure control.
Conclusions: At present, it remains difficult to delineate a precise neuropsychological profile associated with MAE and LGS. The cognitive outcome of MAE is variable and depends on the clinical pattern. With regard to LGS, the hypothesis of a genetic predisposition underlying both the epilepsy and the mental retardation is still valid. Alternatively, exposure to subclinical electrophysiological anomalies during a critical period of cerebral development may be responsible for the mental retardation. At the time the clinical manifestations appear, drug treatment, even if effective, would have only limited impact on cognitive outcome. However, early multidisciplinary intervention may help to improve behavior and communicative abilities, enhancing the quality of life of these children and their families. 相似文献